Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Global Health Innovative Technology (Ghit) Fund

Headquarters: Tokyo, Japan
Year Founded: 2013
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Jan 12, 2022
Management Tracks

Alector’s Robert Paul becomes CEO at Nine Square

Plus Smeal joins Cardiff as CSO and updates from GHIT, Aclaris, Iovance, Pyramid, SomaLogic and more
BioCentury | Apr 1, 2019
Company News

Management tracks: AACR, Acadia, Aerie

BioCentury | Jun 7, 2018
Company News

Management tracks: Alder, BIO

BioCentury | Feb 8, 2018
Finance

External rethink

PPP review: why companies are competing with academics for research partnerships
BioCentury | Jul 20, 2017
Finance

Sharpless edge for NCI

Public funding roundup 2Q17
BioCentury | Jun 16, 2017
Company News

Eisai provides updates on JHU and Broad deals

BioCentury | Jun 2, 2017
Financial News

GHIT secures $200M for next phase

BioCentury | Feb 9, 2017
Finance

Managing Goliaths

PPP management moves front and center as partners focus on what works
Items per page:
1 - 10 of 22